1-3 of 3
Yuhua Huang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab Biosimilar Combined with Pegylated Interferon α-2b in Patients with Untreated Advanced Indolent B-Cell Non-Hodgkin's Lymphoma: Preliminary Results from a Multicenter, Single-Arm, Phase II Study

Gao Yan, Jianqiu Wu, Yunhong Huang, Hui Zhou, Ru Feng, Li Fei, Xiaoxiao Wang, Bing Bai, Yuhua Huang, Haixia He, Liqin Ping, Yanxia He, Cheng Huang, Jibin Li, Jiaying Mao, Huiqiang Huang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1359.
https://doi.org/10.1182/blood-2021-152018
Published: 2021
Journal Articles

Novel Induction Therapy for Newly Diagnosed Extranodal Natural Killer/T Cell Lymphoma (ENKTL) Treated By Anti-PD-1 Antibody Plus Histone Deacetylase Inhibitor Followed By P-GemOx Regimen

Gao Yan, Yujing Zhang, Xiaoxiao Wang, Bing Bai, Yuhua Huang, Haixia He, Liqin Ping, Yanxia He, Cheng Huang, Jibin Li, Jiaying Mao, Huiqiang Huang
Journal: Blood
Blood (2021) 138 (Supplement 1): 137.
https://doi.org/10.1182/blood-2021-147169
Published: 2021
Journal Articles

Identification of Biomarkers Associated with MAF-Mediated Resistance to Proteasome Inhibitors in t(14;16) Multiple Myeloma

Ya-Wei Qiang, Shiqiao Ye, PhD BSc, MSc, Ricky D Edmondson, PhD, Yuhua Huang, Sarah K. Johnson, PhD, Caleb K. Stein, MS, Bart Barlogie, MD PhD, Joshua Epstein, DSc, Gareth J Morgan, MDPhD, Faith E Davies, MD
Journal: Blood
Blood (2015) 126 (23): 3020.
https://doi.org/10.1182/blood.V126.23.3020.3020
Published: 2015